Page last updated: 2024-10-23

benzbromarone and Cirrhosis

benzbromarone has been researched along with Cirrhosis in 2 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Research Excerpts

ExcerptRelevanceReference
"High levels of serum uric acid is closely associated with atrial fibrillation (AF); nonetheless, the detailed mechanisms remain unknown."4.02Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications. ( Li, Y; Liang, D; Liang, Z; Liu, H; Liu, Y; Su, M; Sun, L; Wang, D; Wei, Y; Yin, S; Zhang, G; Zhang, S; Zhao, J, 2021)
" The effect of preventing hyperuricemia was determined by concomitant treatment with a xanthine oxidase inhibitor, allopurinol (CsAALP), or with a uricosuric, benzbromarone (CsABENZ), in drinking water."3.78Use of uric acid-lowering agents limits experimental cyclosporine nephropathy. ( Johnson, RJ; Mazali, FC; Mazzali, M, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, D1
Sun, L1
Zhang, G1
Liu, Y1
Liang, Z1
Zhao, J1
Yin, S1
Su, M1
Zhang, S1
Wei, Y1
Liu, H1
Liang, D1
Li, Y1
Mazali, FC1
Johnson, RJ1
Mazzali, M1

Other Studies

2 other studies available for benzbromarone and Cirrhosis

ArticleYear
Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:3

    Topics: Actins; Animals; Apoptosis; Atrial Fibrillation; Atrial Remodeling; bcl-2-Associated X Protein; Benz

2021
Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
    Nephron. Experimental nephrology, 2012, Volume: 120, Issue:1

    Topics: Allopurinol; Animals; Benzbromarone; Cell Proliferation; Cyclosporine; Enzyme Inhibitors; Fibrosis;

2012